Effect of resveratrol on exercise capacity: A randomized placebo-controlled crossover pilot study

Applied Physiology, Nutrition and Metabolism

Volumn 39, Issue 10, 2014, Pages 1183-1187

  Voduc, Nha ^a   la Porte, Charles ^b   Tessier, Caroline ^c   Mallick, Ranjeeta ^b   Cameron, D William ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Exercise capacity; Resveratrol; Safety; Tolerability

Indexed keywords

RESVERATROL; STILBENE DERIVATIVE;

ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EXERCISE; EXERCISE TOLERANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; STILBENES; YOUNG ADULT;

EID: 84907846491     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2013-0547     Document Type: Article

References (21)

1. Brown, V.A., Patel, K.R., Viskaduraki, M., Crowell, J.A., Perloff, M., Booth, T.D., et al. 2010. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 70(22): 9003–9011. doi:10.1158/0008-5472.CAN-10-2364.
2. Buford, T.W., and Anton, S.D. 2014. Resveratrol as a supplement to exercise training: friend or foe? J. Physiol. 592(3): 551–552. doi:10.1113/jphysiol.2013.267922.
3. Chow, H.-H.S., Garland, L.L., Hsu, C.-H., Vining, D.R., Chew, W.M., Miller, J.A., et al. 2010. Resveratrol modulates drug-and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. (Phila), 3(9): 1168–1175.doi:10.1158/1940-6207.CAPR-09-0155.
4. Crandall, J.P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., et al. 2012. Pilot study of resveratrol in older adults with impaired glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci. 67(12): 1307–1312. doi:10.1093/gerona/glr235.
5. Dolinsky, V.W., Jones, K.E., Sidhu, R.S., Haykowsky, M., Czubryt, M.P., Gordon, T., and Dyck, J.R.B. 2012. Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats. J. Physiol. 590(Pt 11): 2783–2799. doi:10.1113/jphysiol.2012.230490.
6. Gliemann, L., Schmidt, J.F., Olesen, J., Bienso, R.S., Peronard, S.L., Grandjean, S.U., et al. 2013. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J. Physiol. 591(Pt 20): 5047–5059. doi:10.1113/jphysiol.2013.258061.
7. Hart, N., Sarga, L., Csende, Z., Koltai, E., Koch, L.G., Britton, S.L., et al. 2013. Resveratrol enhances exercise training responses in rats selectively bred for high running performance. Food Chem Toxicol. 61: 53–59. doi:10.1016/j.fct.2013.01.051.
8. Howells, L.M., Berry, D.P., Elliott, P.J., Jacobsen, E.W., Hoffman, E., Hegarty, B., et al. 2011. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics and pharmacodynamics. Cancer Prev. Res. (Phila), 4: 1419–1425. doi:10.1158/1940-6207.CAPR-11-0148.
9. la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., and Cameron, W. 2010. Steady-state pharmacokinetics and tolerability of transresveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin. Pharmacokinet. 49(7): 449–454. doi:10.2165/11531820-000000000-00000.
10. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127(6): 1109–1122. doi:10.1016/j.cell.2006.11.013.
11. Magyar, K., Halmosi, R., Palfi, A., Feher, G., Czopf, L., Fulop, A., et al. 2012. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin. Hemorheol. Microcirc. 50(3): 179–187. doi:10.3233/CH-2011-1424.
12. Malaguti, M., Angeloni, C., and Hrelia, S. 2013. Polyphenols in exercise performance and prevention of exercise-induced muscle damage. Oxidative Medicine and Cellular Longevity 2013, Article ID 825928. 9 pp. doi:10.1155/2013/825928.
13. Murase, T., Haramizu, S., Ota, N., and Hase, T. 2009. Suppression of the agingassociated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology, 10(4): 423–434. doi:10.1007/s10522-008-9177-z.
14. Oga, T., Nishimura, K., Tsukino, M., Hajiro, T., Ikeda, A., and Izumi, T. 2000. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am. J. Respir. Crit. Care Med. 161(6): 1897–1901. doi:10.1164/ajrccm.161.6.9905045.
15. Pollack, R.M., and Crandall, J.P. 2013. Resveratrol: therapeutic potential for improving cardiometabolic health. Am. J. Hypertens. 26(11): 1260–1268. doi:10.1093/ajh/hpt165.
16. Smoliga, J.M., and Blanchard, O.L. 2013. Recent data do not provide evidence that resveratrol causes ‘mainly negative’ or ‘adverse’ effects on exercise training in humans. J. Physiol. 591(20): 5251–5252. doi:10.1113/jphysiol.2013.262956.
17. Smoliga, J.M., Colombo, E.S., and Campen, M.J. 2013. A healthier approach to clinical trials evaluating resveratrol for primary prevention of age-related diseases in healthy populations. Aging, 5(7): 495–506.
18. Timmers, S., Konings, E., Bilet, L., Houtkooper, R.H., van de Weijer, T., Goossens, G.H., et al. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14(5): 612–622. doi:10.1016/j.cmet.2011.10.002.
19. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, M.J., Garcia-Almagro, F.J., Ruiz-Ros, J.A., et al. 2012. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am. J. Cardiol. 110(3): 356–363. doi:10.1016/j.amjcard.2012.03.030.
20. Vang, O., Ahmad, N., Baile, C.A., Baur, J.A., Brown, K., Csiszar, A., et al. 2011. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLOS ONE, 6(6): e19881. doi:10.1371/journal.pone.0019881.
21. Wu, R.-E., Huang, W.-C., Liao, C.-C., Chang, Y.-K., Kan, N.-W., and Huang, C.-C. 2013. Resveratrol protects against physical fatigue and improves exercise performance in mice. Molecules, 18(4): 4689–4702. doi:10.3390/molecules18044689.